Merrion Announces Filing for Initial Public Offering in the United States
Wilmington, NC: Merrion Pharmaceuticals Ltd today announced that it has filed a Registration Statement on Form F-1 with the US Securities & Exchange Commission in the United States relating to the proposed initial public offering of its ordinary shares in the form of American Depositary Shares and ordinary shares. Merrion plans to apply to list its American Depositary Shares on the Nasdaq Global Market, and its ordinary shares on the Irish Enterprise Exchange in Dublin, Ireland.
http://www.merrionpharma.com/content/media/press_releases/02-04-07.asp

